Maximilian Regenold

546 total citations
12 papers, 410 citations indexed

About

Maximilian Regenold is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Maximilian Regenold has authored 12 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomaterials, 7 papers in Biomedical Engineering and 4 papers in Molecular Biology. Recurrent topics in Maximilian Regenold's work include Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (5 papers) and RNA Interference and Gene Delivery (3 papers). Maximilian Regenold is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (5 papers) and RNA Interference and Gene Delivery (3 papers). Maximilian Regenold collaborates with scholars based in Canada, Germany and United States. Maximilian Regenold's co-authors include Christine Allen, Michael Dunne, Pauric Bannigan, Trevor D. McKee, James Evans, Marc A. Gauthier, Hoda Soleymani Abyaneh, David N. Dubins, Michael Temple and Adam C. Waspe and has published in prestigious journals such as The Journal of Physical Chemistry B, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Maximilian Regenold

11 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maximilian Regenold Canada 9 246 176 116 50 49 12 410
Cheng-Jung Yao Taiwan 7 186 0.8× 130 0.7× 158 1.4× 50 1.0× 77 1.6× 8 392
Zhiting Sun China 14 205 0.8× 174 1.0× 157 1.4× 33 0.7× 66 1.3× 21 494
Collin T. Inglut United States 6 132 0.5× 111 0.6× 160 1.4× 23 0.5× 78 1.6× 9 371
Guanru Wang China 10 257 1.0× 178 1.0× 183 1.6× 66 1.3× 35 0.7× 21 481
Tianjiao Chu China 9 222 0.9× 140 0.8× 164 1.4× 89 1.8× 44 0.9× 19 523
Heping Qiu China 11 176 0.7× 118 0.7× 93 0.8× 24 0.5× 23 0.5× 19 392
Chuanyou Guo China 6 201 0.8× 192 1.1× 195 1.7× 53 1.1× 22 0.4× 7 392

Countries citing papers authored by Maximilian Regenold

Since Specialization
Citations

This map shows the geographic impact of Maximilian Regenold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Regenold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Regenold more than expected).

Fields of papers citing papers by Maximilian Regenold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian Regenold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Regenold. The network helps show where Maximilian Regenold may publish in the future.

Co-authorship network of co-authors of Maximilian Regenold

This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian Regenold. A scholar is included among the top collaborators of Maximilian Regenold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian Regenold. Maximilian Regenold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Regenold, Maximilian, et al.. (2025). Rapid Release of Doxorubicin from Thermosensitive Liposomes─Contributions of Leakage Versus Unloading. The Journal of Physical Chemistry B. 129(29). 7518–7527.
2.
3.
Babichev, Yael, Maximilian Regenold, Michael P. Dunne, et al.. (2023). Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model. Journal of Visualized Experiments. 2 indexed citations
4.
Regenold, Maximilian, Xuehan Wang, Kan Kaneko, Pauric Bannigan, & Christine Allen. (2022). Harnessing immunotherapy to enhance the systemic anti-tumor effects of thermosensitive liposomes. Drug Delivery and Translational Research. 13(4). 1059–1073. 8 indexed citations
5.
Regenold, Maximilian, Kan Kaneko, Xuehan Wang, et al.. (2022). Triggered release from thermosensitive liposomes improves tumor targeting of vinorelbine. Journal of Controlled Release. 354. 19–33. 19 indexed citations
6.
Regenold, Maximilian, Pauric Bannigan, James Evans, et al.. (2021). Turning down the heat: The case for mild hyperthermia and thermosensitive liposomes. Nanomedicine Nanotechnology Biology and Medicine. 40. 102484–102484. 61 indexed citations
7.
Bannigan, Pauric, James Evans, Michael Dunne, et al.. (2021). Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol. European Journal of Pharmaceutical Sciences. 168. 106058–106058. 39 indexed citations
8.
Abyaneh, Hoda Soleymani, Maximilian Regenold, Trevor D. McKee, Christine Allen, & Marc A. Gauthier. (2020). Towards extracellular matrix normalization for improved treatment of solid tumors. Theranostics. 10(4). 1960–1980. 84 indexed citations
9.
Dunne, Michael, Maximilian Regenold, & Christine Allen. (2020). Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy. Advanced Drug Delivery Reviews. 163-164. 98–124. 111 indexed citations
10.
11.
Regenold, Maximilian, et al.. (2020). Determining critical parameters that influence in vitro performance characteristics of a thermosensitive liposome formulation of vinorelbine. Journal of Controlled Release. 328. 551–561. 14 indexed citations
12.
Dunne, Michael, et al.. (2019). Heat-activated drug delivery increases tumor accumulation of synergistic chemotherapies. Journal of Controlled Release. 308. 197–208. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng-Jung Yao Breakdown of academic impact, for papers by Zhiting Sun Breakdown of academic impact, for papers by Collin T. Inglut Breakdown of academic impact, for papers by Guanru Wang Breakdown of academic impact, for papers by Tianjiao Chu Breakdown of academic impact, for papers by Heping Qiu Breakdown of academic impact, for papers by Chuanyou Guo
Rankless by CCL
2026